Angiotensin converting-enzyme inhibitors and candesartan have no effects on atrial fibrillation after cardiac surgery: comment on: Mehmet Ozaydin et al. "Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation"

Int J Cardiol. 2010 Jul 9;142(2):209-10. doi: 10.1016/j.ijcard.2008.11.161. Epub 2008 Dec 19.

Abstract

The manuscript is a "Letter to the Editor" concerning the paper: "Ozaydin M, Dede O, Varol E, et al. Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation. Int J Cardiol 2008; 127: 362-367".

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / etiology
  • Atrial Fibrillation / metabolism
  • Benzimidazoles / administration & dosage*
  • Biphenyl Compounds
  • Cardiac Surgical Procedures / adverse effects*
  • Humans
  • Mineralocorticoid Receptor Antagonists / administration & dosage
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / etiology
  • Postoperative Complications / metabolism
  • Prospective Studies
  • Renin-Angiotensin System / drug effects*
  • Renin-Angiotensin System / physiology
  • Tetrazoles / administration & dosage*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Biphenyl Compounds
  • Mineralocorticoid Receptor Antagonists
  • Tetrazoles
  • candesartan